Showing results (1691-1700 of 1,820) with videos related to
Sort By:
Pageof 182
Genome Medicine|July 17, 2023
Ancestry-driven metabolite variation provides insights into disease states in admixed populationsKaylia M Reynolds, Andrea R V R Horimoto, Bridget M Lin, et al.Cancer Research|November 14, 1997
Induction of apoptosis and cell cycle arrest by CP-358,774, an inhibitor of epidermal growth factor receptor tyrosine kinaseJ D Moyer, E G Barbacci, K K Iwata, et al.American Journal of Human Genetics|October 27, 1997
A spectrum of mutations in the second gene for autosomal dominant polycystic kidney disease (PKD2)B Veldhuisen, J J Saris, S de Haij, et al.Cell Reports|November 7, 2019
Hepatocytes Delete Regulatory T Cells by Enclysis, a CD4+ T Cell Engulfment ProcessScott P Davies, Gary M Reynolds, Alex L Wilkinson, et al.Infectious Diseases of Poverty|December 8, 2024
Waning success: a 2013-2022 spatial and temporal trend analysis of malaria in EthiopiaAbdollah Jalilian, Galana Mamo Ayana, Temesgen Ashine, et al.BJOG : an International Journal of Obstetrics and Gynaecology|November 15, 2023
Impact of COVID-19 on gestational diabetes pregnancy outcomes in the UK: A multicentre retrospective cohort studyNiamh-Maire Mclennan, Robert Lindsay, Ponnusamy Saravanan, et al.Journal of Hepatology|December 20, 2011
A dual role for hypoxia inducible factor-1α in the hepatitis C virus lifecycle and hepatoma migrationGarrick K Wilson, Claire L Brimacombe, Ian A Rowe, et al.Trials|August 24, 2024
LSDDEP2: study protocol for a randomised, double-dummy, triple-blind, active placebo-controlled, parallel groups trial of LSD microdosing in patients with major depressive disorderDimitri Daldegan-Bueno, Carina Joy Donegan, Anna Forsyth, et al.Cold Spring Harbor Molecular Case Studies|November 15, 2022
Rapid genome sequencing identifies a novel de novo SNAP25 variant for neonatal congenital myasthenic syndromeHayley M Reynolds, Ting Wen, Andrew Farrell, et al.Archives of Ophthalmology (Chicago, Ill. : 1960)|December 14, 2005
Development of metastatic disease after enrollment in the COMS trials for treatment of choroidal melanoma: Collaborative Ocular Melanoma Study Group Report No. 26Marie Diener-West, Sandra M Reynolds, Donna J Agugliaro, et al.Pageof 182